NORA GARCIA-FLORES: Open Payments
NPI 1285151399 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 28 payments from 19 companies in 2025. Trend: 2023 $870 · 2024 $456 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $124 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Incyte Corporation | 3 | $70 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| JAZZ PHARMACEUTICALS INC. | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Gilead Sciences, Inc. | 1 | $34 |
| ARRAY BIOPHARMA INC | 1 | $30 |
Products named: Xtandi, ENHERTU, KEYTRUDA, KISQALI, ZIIHERA, REZUROCK, DATROWAY, XALKORI.
Industry payments across FL — which companies pay providers there.
